Clinical Strategies to Prevent Acute Respiratory Distress Syndrome

Abstract

Acute respiratory distress syndrome (ARDS) remains an important clinical entity in the intensive care unit with a significant impact on morbidity and mortality. Effective therapeutic interventions are limited; thus current research focus has shifted from treatment to the prevention of this pulmonary syndrome. In recent decades, a decrease in the incidence of ARDS has been observed and this reduction is largely due to preventive strategies including safe lung ventilation practices, avoidance of iatrogenic exposures, and improvement in care of predisposing conditions such as sepsis and pneumonia. Early identification of at-risk patients, prompt treatment of predisposing conditions, and adoption of evidence-based best practice including restrictive transfusion strategies, conservative fluid management, avoidance of large tidal volume ventilation, and aspiration precaution practices are key preventive strategies with demonstrated benefits. There are currently no effective pharmacological preventive strategies for ARDS.

Keywords

acute respiratory distress syndrome - acute lung injury - prevention

Authors' Contribution

Yewande O, Svetlana H, Michelle G, and Ognjen G contributed to writing of the article, provided intellectual contributions to the content, and made critical revisions; all authors reviewed and approved the final version of the article.

• References

• 1 Bellani G, Laffey JG, Pham T. , et al; LUNG SAFE Investigators; ESICM Trials Group. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA 2016; 315 (08) 788-800
• 2 Matthay MA, Zimmerman GA, Esmon C. , et al. Future research directions in acute lung injury: summary of a National Heart, Lung, and Blood Institute working group. Am J Respir Crit Care Med 2003; 167 (07) 1027-1035
• 3 de Haro C, Martin-Loeches I, Torrents E, Artigas A. Acute respiratory distress syndrome: prevention and early recognition. Ann Intensive Care 2013; 3 (01) 11
• 4 Li G, Malinchoc M, Cartin-Ceba R. , et al. Eight-year trend of acute respiratory distress syndrome: a population-based study in Olmsted County, Minnesota. Am J Respir Crit Care Med 2011; 183 (01) 59-66
• 5 Spragg RG, Bernard GR, Checkley W. , et al. Beyond mortality: future clinical research in acute lung injury. Am J Respir Crit Care Med 2010; 181 (10) 1121-1127
• 6 Gong MN, Thompson BT. Acute respiratory distress syndrome: shifting the emphasis from treatment to prevention. Curr Opin Crit Care 2016; 22 (01) 21-37
• 7 Ranieri VM, Rubenfeld GD, Thompson BT. , et al; ARDS Definition Task Force. Acute respiratory distress syndrome: the Berlin definition. JAMA 2012; 307 (23) 2526-2533
• 8 Morrill HJ, Caffrey AR, Noh E, LaPlante KL. Epidemiology of pneumococcal disease in a national cohort of older adults. Infect Dis Ther 2014; 3 (01) 19-33
• 9 Bautista E, Chotpitayasunondh T, Gao Z. , et al; Writing Committee of the WHO Consultation on Clinical Aspects of Pandemic (H1N1) 2009 Influenza. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med 2010; 362 (18) 1708-1719
• 10 Kumar A, Zarychanski R, Pinto R. , et al; Canadian Critical Care Trials Group H1N1 Collaborative. Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA 2009; 302 (17) 1872-1879
• 11 Webb SA, Pettilä V, Seppelt I. , et al; ANZIC Influenza Investigators. Critical care services and 2009 H1N1 influenza in Australia and New Zealand. N Engl J Med 2009; 361 (20) 1925-1934
• 12 Moberley S, Holden J, Tatham DP, Andrews RM. Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev 2013; (01) CD000422
• 13 Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis 2012; 12 (01) 36-44
• 14 Tomczyk S, Bennett NM, Stoecker C. , et al; Centers for Disease Control and Prevention (CDC). Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged ≥65 years: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2014; 63 (37) 822-825
• 15 Ahmed AH, Litell JM, Malinchoc M. , et al. The role of potentially preventable hospital exposures in the development of acute respiratory distress syndrome: a population-based study. Crit Care Med 2014; 42 (01) 31-39
• 16 Zhao JN, Liu Y, Li HC. Aspiration-related acute respiratory distress syndrome in acute stroke patient. PLoS One 2015; 10 (03) e0118682
• 17 Raghavendran K, Nemzek J, Napolitano LM, Knight PR. Aspiration-induced lung injury. Crit Care Med 2011; 39 (04) 818-826
• 18 Lee A, Festic E, Park PK. , et al; United States Critical Illness and Injury Trials Group. Characteristics and outcomes of patients hospitalized following pulmonary aspiration. Chest 2014; 146 (04) 899-907
• 19 Yadav H, Thompson BT, Gajic O. Fifty years of research in ARDS. Is acute respiratory distress syndrome a preventable disease?. Am J Respir Crit Care Med 2017; 195 (06) 725-736
• 20 Warner MA. Is pulmonary aspiration still an important problem in anesthesia?. Curr Opin Anaesthesiol 2000; 13 (02) 215-218
• 21 American Society of Anesthesiologists Committee. Practice guidelines for preoperative fasting and the use of pharmacologic agents to reduce the risk of pulmonary aspiration: application to healthy patients undergoing elective procedures: an updated report by the American Society of Anesthesiologists Committee on Standards and Practice Parameters. Anesthesiology 2011; 114 (03) 495-511
• 22 Moss M, Parsons PE, Steinberg KP. , et al. Chronic alcohol abuse is associated with an increased incidence of acute respiratory distress syndrome and severity of multiple organ dysfunction in patients with septic shock. Crit Care Med 2003; 31 (03) 869-877
• 23 Calfee CS, Matthay MA, Kangelaris KN. , et al. Cigarette smoke exposure and the acute respiratory distress syndrome. Crit Care Med 2015; 43 (09) 1790-1797
• 24 Ware LB, Zhao Z, Koyama T. , et al. Long-term ozone exposure increases the risk of developing the acute respiratory distress syndrome. Am J Respir Crit Care Med 2016; 193 (10) 1143-1150
• 25 Trillo-Alvarez C, Cartin-Ceba R, Kor DJ. , et al. Acute lung injury prediction score: derivation and validation in a population-based sample. Eur Respir J 2011; 37 (03) 604-609
• 26 Gajic O, Dabbagh O, Park PK. , et al; U.S. Critical Illness and Injury Trials Group: Lung Injury Prevention Study Investigators (USCIITG-LIPS). Early identification of patients at risk of acute lung injury: evaluation of lung injury prediction score in a multicenter cohort study. Am J Respir Crit Care Med 2011; 183 (04) 462-470
• 27 Kor DJ, Carter RE, Park PK. , et al; US Critical Illness and Injury Trials Group: Lung Injury Prevention with Aspirin Study Group (USCIITG: LIPS-A). Effect of aspirin on development of ARDS in at-risk patients presenting to the emergency department: the lips-a randomized clinical trial. JAMA 2016; 315 (22) 2406-2414
• 28 Levitt JE, Calfee CS, Goldstein BA, Vojnik R, Matthay MA. Early acute lung injury: criteria for identifying lung injury prior to the need for positive pressure ventilation*. Crit Care Med 2013; 41 (08) 1929-1937
• 29 Festic E, Bansal V, Kor DJ, Gajic O. ; US Critical Illness and Injury Trials Group: Lung Injury Prevention Study Investigators (USCIITG–LIPS). SpO2/FiO2 ratio on hospital admission is an indicator of early acute respiratory distress syndrome development among patients at risk. J Intensive Care Med 2015; 30 (04) 209-216
• 30 Bice T, Li G, Malinchoc M, Lee AS, Gajic O. Incidence and risk factors of recurrent acute lung injury. Crit Care Med 2011; 39 (05) 1069-1073
• 31 Wind J, Versteegt J, Twisk J. , et al. Epidemiology of acute lung injury and acute respiratory distress syndrome in The Netherlands: a survey. Respir Med 2007; 101 (10) 2091-2098
• 32 Torres A, Sibila O, Ferrer M. , et al. Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial. JAMA 2015; 313 (07) 677-686
• 33 Fuller BM, Ferguson I, Mohr NM. , et al. Lung-protective ventilation initiated in the emergency department (LOV-ED): a study protocol for a quasi-experimental, before-after trial aimed at reducing pulmonary complications. BMJ Open 2016; 6 (04) e010991
• 34 Hou PC, Elie-Turenne MC, Mitani A. , et al; US Critical Illness and Injury Trials Group: Lung Injury Prevention Study Investigators (USCIITG–LIPS 1). Towards prevention of acute lung injury: frequency and outcomes of emergency department patients at-risk - a multicenter cohort study. Int J Emerg Med 2012; 5 (01) 22
• 35 Villar J, Kacmarek RM, Hedenstierna G. From ventilator-induced lung injury to physician-induced lung injury: why the reluctance to use small tidal volumes?. Acta Anaesthesiol Scand 2004; 48 (03) 267-271
• 36 Villar J, Slutsky AS. Is acute respiratory distress syndrome an iatrogenic disease?. Crit Care 2010; 14 (01) 120
• 37 Toy P, Gajic O, Bacchetti P. , et al; TRALI Study Group. Transfusion-related acute lung injury: incidence and risk factors. Blood 2012; 119 (07) 1757-1767
• 38 Institute of Medicine Committee on Quality of Health Care in America. In: Kohn LT, Corrigan JM, Donaldson MS. , eds. To Err is Human: Building a Safer Health System. Washington (DC): National Academies Press (US); 2000
• 39 Gajic O, Dara SI, Mendez JL. , et al. Ventilator-associated lung injury in patients without acute lung injury at the onset of mechanical ventilation. Crit Care Med 2004; 32 (09) 1817-1824
• 40 Serpa Neto A, Simonis FD, Barbas CS. , et al. Association between tidal volume size, duration of ventilation, and sedation needs in patients without acute respiratory distress syndrome: an individual patient data meta-analysis. Intensive Care Med 2014; 40 (07) 950-957
• 41 Simonis FD, Serpa Neto A, Binnekade JM. , et al; Writing Group for the PReVENT Investigators. Effect of a low vs intermediate tidal volume strategy on ventilator-free days in intensive care unit patients without ARDS: a randomized clinical trial. JAMA 2018; 320 (18) 1872-1880
• 42 Kor DJ, Talmor DS, Banner-Goodspeed VM. , et al; US Critical Illness and Injury Trials Group: Lung Injury Prevention with Aspirin Study Group (USCIITG: LIPS-A). Lung Injury Prevention with Aspirin (LIPS-A): a protocol for a multicentre randomised clinical trial in medical patients at high risk of acute lung injury. BMJ Open 2012; 2 (05) 2
• 43 Brochard L, Slutsky A, Pesenti A. Mechanical ventilation to minimize progression of lung injury in acute respiratory failure. Am J Respir Crit Care Med 2017; 195 (04) 438-442
• 44 Scaravilli V, Grasselli G, Castagna L. , et al. Prone positioning improves oxygenation in spontaneously breathing nonintubated patients with hypoxemic acute respiratory failure: a retrospective study. J Crit Care 2015; 30 (06) 1390-1394
• 45 Lemyze M, Mallat J, Duhamel A. , et al. Effects of sitting position and applied positive end-expiratory pressure on respiratory mechanics of critically ill obese patients receiving mechanical ventilation*. Crit Care Med 2013; 41 (11) 2592-2599
• 46 Fernández-Pérez ER, Sprung J, Afessa B. , et al. Intraoperative ventilator settings and acute lung injury after elective surgery: a nested case control study. Thorax 2009; 64 (02) 121-127
• 47 Kor DJ, Warner DO, Alsara A. , et al. Derivation and diagnostic accuracy of the surgical lung injury prediction model. Anesthesiology 2011; 115 (01) 117-128
• 48 Kor DJ, Lingineni RK, Gajic O. , et al. Predicting risk of postoperative lung injury in high-risk surgical patients: a multicenter cohort study. Anesthesiology 2014; 120 (05) 1168-1181
• 49 Park SH. Perioperative lung-protective ventilation strategy reduces postoperative pulmonary complications in patients undergoing thoracic and major abdominal surgery. Korean J Anesthesiol 2016; 69 (01) 3-7
• 50 Güldner A, Kiss T, Serpa Neto A. , et al. Intraoperative protective mechanical ventilation for prevention of postoperative pulmonary complications: a comprehensive review of the role of tidal volume, positive end-expiratory pressure, and lung recruitment maneuvers. Anesthesiology 2015; 123 (03) 692-713
• 51 Matthay MA, Zemans RL. The acute respiratory distress syndrome: pathogenesis and treatment. Annu Rev Pathol 2011; 6: 147-163
• 52 Baudouin SV. Manipulation of inflammation in ARDS: achievable goal or distant target?. Thorax 2006; 61 (06) 464-465
• 53 Ortiz-Diaz E, Festic E, Gajic O, Levitt JE. Emerging pharmacological therapies for prevention and early treatment of acute lung injury. Semin Respir Crit Care Med 2013; 34 (04) 448-458
• 54 Sakuma T, Gu X, Wang Z. , et al. Stimulation of alveolar epithelial fluid clearance in human lungs by exogenous epinephrine. Crit Care Med 2006; 34 (03) 676-681
• 55 Walther S, Jansson I, Berg S, Lennquist S. Pulmonary granulocyte accumulation is reduced by nebulized corticosteroid in septic pigs. Acta Anaesthesiol Scand 1992; 36 (07) 651-655
• 56 Perkins GD, McAuley DF, Thickett DR, Gao F. The beta-agonist lung injury trial (BALTI): a randomized placebo-controlled clinical trial. Am J Respir Crit Care Med 2006; 173 (03) 281-287
• 57 Festic E, Carr GE, Cartin-Ceba R. , et al. Randomized clinical trial of a combination of an inhaled corticosteroid and beta agonist in patients at risk of developing the acute respiratory distress syndrome. Crit Care Med 2017; 45 (05) 798-805
• 58 Miller AC, Elamin EM, Suffredini AF. Inhaled anticoagulation regimens for the treatment of smoke inhalation-associated acute lung injury: a systematic review. Crit Care Med 2014; 42 (02) 413-419
• 59 Dixon B, Schultz MJ, Smith R, Fink JB, Santamaria JD, Campbell DJ. Nebulized heparin is associated with fewer days of mechanical ventilation in critically ill patients: a randomized controlled trial. Crit Care 2010; 14 (05) R180
• 60 Gould NS, Gauthier S, Kariya CT, Min E, Huang J, Brian DJ. Hypertonic saline increases lung epithelial lining fluid glutathione and thiocyanate: two protective CFTR-dependent thiols against oxidative injury. Respir Res 2010; 11: 119
• 61 Wohlauer M, Moore EE, Silliman CC. , et al. Nebulized hypertonic saline attenuates acute lung injury following trauma and hemorrhagic shock via inhibition of matrix metalloproteinase-13. Crit Care Med 2012; 40 (09) 2647-2653
• 62 Zarbock A, Ley K. The role of platelets in acute lung injury (ALI). Front Biosci 2009; 14: 150-158
• 63 Yadav H, Kor DJ. Platelets in the pathogenesis of acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol 2015; 309 (09) L915-L923
• 64 Erlich JM, Talmor DS, Cartin-Ceba R, Gajic O, Kor DJ. Prehospitalization antiplatelet therapy is associated with a reduced incidence of acute lung injury: a population-based cohort study. Chest 2011; 139 (02) 289-295
• 65 Chen W, Janz DR, Bastarache JA. , et al. Prehospital aspirin use is associated with reduced risk of acute respiratory distress syndrome in critically ill patients: a propensity-adjusted analysis. Crit Care Med 2015; 43 (04) 801-807
• 66 Abdulnour RE, Gunderson T, Barkas I. , et al. Early intravascular events are associated with development of acute respiratory distress syndrome. a substudy of the LIPS-A clinical rrial. Am J Respir Crit Care Med 2018; 197 (12) 1575-1585
• 67 McAuley DF, Laffey JG, O'Kane CM. , et al; HARP-2 Investigators; Irish Critical Care Trials Group. Simvastatin in the acute respiratory distress syndrome. N Engl J Med 2014; 371 (18) 1695-1703
• 68 O'Neal Jr HR, Koyama T, Koehler EA. , et al. Prehospital statin and aspirin use and the prevalence of severe sepsis and acute lung injury/acute respiratory distress syndrome. Crit Care Med 2011; 39 (06) 1343-1350
• 69 Yadav H, Lingineni RK, Slivinski EJ. , et al. Preoperative statin administration does not protect against early postoperative acute respiratory distress syndrome: a retrospective cohort study. Anesth Analg 2014; 119 (04) 891-898
• 70 Festic E, Kor DJ, Gajic O. Prevention of acute respiratory distress syndrome. Curr Opin Crit Care 2015; 21 (01) 82-90
• 71 Belvisi MG, Hele DJ. Peroxisome proliferator-activated receptors as novel targets in lung disease. Chest 2008; 134 (01) 152-157
• 72 Kulkarni AA, Woeller CF, Thatcher TH, Ramon S, Phipps RP, Sime PJ. Emerging PPARγ-independent role of PPARγ ligands in lung diseases. PPAR Res 2012; 2012: 705352
• 73 Dwivedi AJ, Wu R, Nguyen E. , et al. Adrenomedullin and adrenomedullin binding protein-1 prevent acute lung injury after gut ischemia-reperfusion. J Am Coll Surg 2007; 205 (02) 284-293
• 74 Rawal G, Yadav S, Kumar R. Post-intensive care syndrome: an overview. J Transl Int Med 2017; 5 (02) 90-92
• 75 Marra A, Ely EW, Pandharipande PP, Patel MB. The ABCDEF bundle in critical care. Crit Care Clin 2017; 33 (02) 225-243
• 76 Patel MB, Jackson JC, Morandi A. , et al. Incidence and risk factors for intensive care unit-related post-traumatic stress disorder in veterans and civilians. Am J Respir Crit Care Med 2016; 193 (12) 1373-1381
• 77 Jackson JC, Pandharipande PP, Girard TD. , et al; Bringing to light the Risk Factors And Incidence of Neuropsychological dysfunction in ICU survivors (BRAIN-ICU) study investigators. Depression, post-traumatic stress disorder, and functional disability in survivors of critical illness in the BRAIN-ICU study: a longitudinal cohort study. Lancet Respir Med 2014; 2 (05) 369-379
• 78 Ehlenbach WJ, Hough CL, Crane PK. , et al. Association between acute care and critical illness hospitalization and cognitive function in older adults. JAMA 2010; 303 (08) 763-770
• 79 Fan E, Dowdy DW, Colantuoni E. , et al. Physical complications in acute lung injury survivors: a two-year longitudinal prospective study. Crit Care Med 2014; 42 (04) 849-859
• 80 Rubenfeld GD. Confronting the frustrations of negative clinical trials in acute respiratory distress syndrome. Ann Am Thorac Soc 2015; 12 (Suppl. 01) S58-S63
• 81 Vincent JL. We should abandon randomized controlled trials in the intensive care unit. Crit Care Med 2010; 38 (10, Suppl): S534-S538